Risk factors for 30-day mortality in patients with head and neck cancer bleeding in the emergency department

Acute head and neck cancer (HNC) bleeding is a life-threatening situation that frequently presents to the emergency department (ED). The purpose of the present study was to analyze the risk factors for the 30-day mortality in patients with HNC bleeding. We included patients who presented to the ED w...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of emergency medicine Vol. 58; pp. 9 - 15
Main Authors Yen, Chieh-Ching, Yeh, Heng, Ho, Che-Fang, Hsiao, Chien-Han, Niu, Kuang-Yu, Yeh, Chung-Cheng, Lu, Jian-Xun, Wu, Chia-Chien, Chang, Yun-Chen, Ng, Chip-Jin
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.08.2022
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Acute head and neck cancer (HNC) bleeding is a life-threatening situation that frequently presents to the emergency department (ED). The purpose of the present study was to analyze the risk factors for the 30-day mortality in patients with HNC bleeding. We included patients who presented to the ED with HNC bleeding (n = 241). Patients were divided into the survivor and nonsurvivor groups. Variables were compared, and the associated factors were examined with Cox's proportional hazard model. Of the 241 patients enrolled, the most common bleeding site was the oral cavity (n = 101, 41.9%). More than half of the patients had advanced HNC stage while 41.5% had local recurrence. The proportion of active bleeding was significantly higher in the nonsurvivor group (70.5% vs. 53.3%, p = 0.038). 42.3% received blood transfusion and 5.0% required inotropic support. In total, 21.2% of the patients experienced rebleeding, and 18.3% died within 30 days. Multivariate analyses indicated that a heart rate > 100 (beats/min) (HR = 2.42; Cl 1.15–5.06; p = 0.019) and inotropic support (HR = 3.00; Cl 1.14–7.89; p = 0.026) were statistically significant independent risk factors for 30-day mortality. The results of this study may aid physicians in the evaluation of short-term survival in HNC bleeding patients and provide critical information for risk stratification and medical decisions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0735-6757
1532-8171
DOI:10.1016/j.ajem.2022.05.008